UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis

Annals of the rheumatic diseases, 2009-10, Vol.68 (10), p.1621-1625

2009

Volltextzugriff (PDF)

SAT0189 Use of Anti-200/100 Antibody in the Evaluation of Statin Induced Myositis: Experience of a UK Based Tertiary Myositis-Referral Centre

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A645-A645

2013

Volltextzugriff (PDF)

Autoantibodies to a 140‐kd protein in juvenile dermatomyositis are associated with calcinosis

Arthritis and rheumatism, 2009-06, Vol.60 (6), p.1807-1814

2009

Volltextzugriff (PDF)

SAT0197 B Cell Activating Factor (BAFF) Correlate with Disease Activity and Antibody Levels in Anti-Pm-Scl Positive Patients with Idiopathic Inflammatory Myopathies

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A647-A648

2013

Volltextzugriff (PDF)

Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression

Rheumatology (Oxford, England), 2009-06, Vol.48 (6), p.607-612

2009

Volltextzugriff (PDF)

Evidence for a role of ganglioside GM1 in antigen presentation: binding enhances presentation of Escherichia coli enterotoxin B subunit (EtxB) to CD4+ T cells

International immunology, 2001-04, Vol.13 (4), p.541-551

2001

Volltextzugriff (PDF)

PReS-FINAL-2130: Antibodies to MDA5 correlate with a distinct phenotype in children with juvenile dermatomyositis, including higher risk of lung involvement and ulcerative skin disease

Pediatric rheumatology online journal, 2013-12, Vol.11 (S2), p.P142-P142, Article P142

2013

Volltextzugriff (PDF)

Antigen binding to G(M1) ganglioside results in delayed presentation: Minimal effects of G(M1) on presentation of antigens internalized via other pathways

Immunology, 2002-05, Vol.106 (1), p.60

2002

Volltextzugriff (PDF)

8.4 Novel autoantibodies targeting a p140 protein are a major autoantigen system in juvenile dermatomyositis and a marker of calcinosis

Pediatric rheumatology online journal, 2008-09, Vol.6 (S1), p.S18-S18, Article S18

2008

Volltextzugriff (PDF)

Antigen binding to G sub(M1) ganglioside results in delayed presentation: minimal effects of G sub(M1) on presentation of antigens internalized via other pathways

Immunology, 2002-05, Vol.106 (1), p.60-70

2002

Volltextzugriff (PDF)

Evidence for a role of ganglioside GM sub(1) in antigen presentation: binding enhances presentation of Escherichia coli enterotoxin B subunit (EtxB) to CD4 super(+) T cells

International immunology, 2001-04, Vol.13 (4), p.541-551

2001

Volltextzugriff (PDF)

Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients

Journal of autoimmunity, 2019-07, Vol.101, p.48-55

2019

Volltextzugriff (PDF)

Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis

Rheumatology (Oxford, England), 2008-03, Vol.47 (3), p.324-328

2008

Volltextzugriff (PDF)

Dysfunction of endothelial progenitor cells is associated with the type I IFN pathway in patients with polymyositis and dermatomyositis

Rheumatology (Oxford, England), 2016-11, Vol.55 (11), p.1987-1992

2016

Volltextzugriff (PDF)

Autoantibody Specificities and Type I Interferon Pathway Activation in Idiopathic Inflammatory Myopathies

Scandinavian journal of immunology, 2016-08, Vol.84 (2), p.100-109

2016

Volltextzugriff (PDF)

HLA–DPB1 associations differ between DRB103 positive anti-Jo-1 and anti-PM-Scl antibody positive idiopathic inflammatory myopathy

Rheumatology (Oxford, England), 2009-10, Vol.48 (10), p.1213-1217

2009

Volltextzugriff (PDF)

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD – Summary

Diabetes & vascular disease research, 2014-05, Vol.11 (3), p.133-173

2014

Volltextzugriff (PDF)

THU0253 ANTI-PM-SCL autoantibodies in polymyositis and dermatomyositis

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.240-240

2013

Volltextzugriff (PDF)

Do European people with type 1 diabetes consume a high atherogenic diet? 7-year follow-up of the EURODIAB Prospective Complications Study

European journal of nutrition, 2013-10, Vol.52 (7), p.1701-1710

2013

Volltextzugriff (PDF)

Serum high-mobility group box-1 levels are positively associated with micro- and macroalbuminuria but not with cardiovascular disease in type 1 diabetes: the EURODIAB Prospective Complications Study

European journal of endocrinology, 2012-02, Vol.166 (2), p.325

2012

Volltextzugriff (PDF)

ANTI-PM-SCL AUTOANTIBODIES IN POLYMYOSITIS AND DERMATOMYOSITIS

ANNALS OF THE RHEUMATIC DISEASES, 2013, Vol.71, p.240

2013

Volltextzugriff (PDF)

Clinical associations of autoantibodies to a pl55/140kDa doublet protein in juvenile dermatomyositis

Rheumatology (Oxford, England), 2008, Vol.47 (3), p.324-328

2008

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(27)
Tagungsberichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Humans
(17)
Adult
(13)
Female
(13)
Male
(12)
Medicin Och Hälsovetenskap
(10)
Middle Aged
(10)
Biological And Medical Sciences
(9)
Medical Sciences
(9)
Rheumatology
(9)
Aged
(6)
Dermatomyositis - Immunology
(6)
Autoantibodies
(5)
Autoantibodies - Immunology
(5)
Diseases Of Striated Muscles. Neuromuscular Diseases
(5)
Diseases Of The Osteoarticular System
(5)
Myositis - Immunology
(5)
Neurology
(5)
Risk Factors
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis

SAT0189 Use of Anti-200/100 Antibody in the Evaluation of Statin Induced Myositis: Experience of a UK Based Tertiary Myositis-Referral Centre

Autoantibodies to a 140‐kd protein in juvenile dermatomyositis are associated with calcinosis

SAT0197 B Cell Activating Factor (BAFF) Correlate with Disease Activity and Antibody Levels in Anti-Pm-Scl Positive Patients with Idiopathic Inflammatory Myopathies

Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression

Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups

Evidence for a role of ganglioside GM1 in antigen presentation: binding enhances presentation of Escherichia coli enterotoxin B subunit (EtxB) to CD4+ T cells

PReS-FINAL-2130: Antibodies to MDA5 correlate with a distinct phenotype in children with juvenile dermatomyositis, including higher risk of lung involvement and ulcerative skin disease

Antigen binding to G(M1) ganglioside results in delayed presentation: Minimal effects of G(M1) on presentation of antigens internalized via other pathways

8.4 Novel autoantibodies targeting a p140 protein are a major autoantigen system in juvenile dermatomyositis and a marker of calcinosis

Antigen binding to G sub(M1) ganglioside results in delayed presentation: minimal effects of G sub(M1) on presentation of antigens internalized via other pathways

Evidence for a role of ganglioside GM sub(1) in antigen presentation: binding enhances presentation of Escherichia coli enterotoxin B subunit (EtxB) to CD4 super(+) T cells

Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis

Dysfunction of endothelial progenitor cells is associated with the type I IFN pathway in patients with polymyositis and dermatomyositis

Autoantibody Specificities and Type I Interferon Pathway Activation in Idiopathic Inflammatory Myopathies

HLA–DPB1 associations differ between DRB103 positive anti-Jo-1 and anti-PM-Scl antibody positive idiopathic inflammatory myopathy

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD – Summary

Response to: 'Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria' by Cavagna et al

THU0253 ANTI-PM-SCL autoantibodies in polymyositis and dermatomyositis

Do European people with type 1 diabetes consume a high atherogenic diet? 7-year follow-up of the EURODIAB Prospective Complications Study

Serum high-mobility group box-1 levels are positively associated with micro- and macroalbuminuria but not with cardiovascular disease in type 1 diabetes: the EURODIAB Prospective Complications Study

ANTI-PM-SCL AUTOANTIBODIES IN POLYMYOSITIS AND DERMATOMYOSITIS

Clinical associations of autoantibodies to a pl55/140kDa doublet protein in juvenile dermatomyositis

Suchergebnisse filtern